[HTML][HTML] BDNF signaling in context: From synaptic regulation to psychiatric disorders

CS Wang, ET Kavalali, LM Monteggia - Cell, 2022 - cell.com
Brain-derived neurotrophic factor (BDNF) is a neuropeptide that plays numerous important
roles in synaptic development and plasticity. While its importance in fundamental physiology …

[HTML][HTML] Brain-derived neurotrophic factor signaling in depression and antidepressant action

E Castrén, LM Monteggia - Biological psychiatry, 2021 - Elsevier
Neurotrophic factors, particularly BDNF (brain-derived neurotrophic factor), have been
associated with depression and antidepressant drug action. A variety of preclinical and …

[HTML][HTML] Psychedelics reopen the social reward learning critical period

R Nardou, E Sawyer, YJ Song, M Wilkinson… - Nature, 2023 - nature.com
Psychedelics are a broad class of drugs defined by their ability to induce an altered state of
consciousness,. These drugs have been used for millennia in both spiritual and medicinal …

Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor

P Georgiou, P Zanos, TCM Mou, X An… - Nature …, 2022 - nature.com
We show that the sex of human experimenters affects mouse behaviors and responses
following administration of the rapid-acting antidepressant ketamine and its bioactive …

mTOR at the nexus of nutrition, growth, ageing and disease

GY Liu, DM Sabatini - Nature reviews Molecular cell biology, 2020 - nature.com
The mTOR pathway integrates a diverse set of environmental cues, such as growth factor
signals and nutritional status, to direct eukaryotic cell growth. Over the past two and a half …

Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics

LR Aleksandrova, AG Phillips - Trends in pharmacological sciences, 2021 - cell.com
The emerging therapeutic efficacy of ketamine and classical psychedelics for depression
has inspired tremendous interest in the underlying neurobiological mechanisms. We review …

[HTML][HTML] Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb

S Ma, M Chen, Y Jiang, X Xiang, S Wang, Z Wu, S Li… - Nature, 2023 - nature.com
Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, has revolutionized the
treatment of depression because of its potent, rapid and sustained antidepressant effects …

[HTML][HTML] Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine

W Yao, Q Cao, S Luo, L He, C Yang, J Chen, Q Qi… - Molecular …, 2022 - nature.com
Abstract (R, S)-ketamine elicits rapid-acting and sustained antidepressant actions in
treatment-resistant patients with depression.(R)-ketamine produces longer-lasting …

[HTML][HTML] Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments

RS Duman, G Sanacora, JH Krystal - Neuron, 2019 - cell.com
The mechanisms underlying the pathophysiology and treatment of depression and stress-
related disorders remain unclear, but studies in depressed patients and rodent models are …

[HTML][HTML] Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Y Wei, L Chang, K Hashimoto - Molecular Psychiatry, 2022 - nature.com
The discovery of robust antidepressant actions exerted by the N-methyl-D-aspartate receptor
(NMDAR) antagonist (R, S)-ketamine has been a crucial breakthrough in mood disorder …